Ziqiang Luo

2.6k total citations
101 papers, 1.9k citations indexed

About

Ziqiang Luo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Ziqiang Luo has authored 101 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 24 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Ziqiang Luo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Neonatal Respiratory Health Research (21 papers) and Neuroscience of respiration and sleep (9 papers). Ziqiang Luo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Neonatal Respiratory Health Research (21 papers) and Neuroscience of respiration and sleep (9 papers). Ziqiang Luo collaborates with scholars based in China, United States and Australia. Ziqiang Luo's co-authors include Shaojie Yue, Dandan Feng, Xiaoting Huang, Xiaohong Li, Yan Zhou, Siyuan Tang, Jianzhong Han, Wei Liu, Chen Chen and Qingmei Cheng and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Ziqiang Luo

96 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziqiang Luo China 25 696 564 245 232 150 101 1.9k
Joong‐Sun Kim South Korea 30 968 1.4× 649 1.2× 135 0.6× 267 1.2× 213 1.4× 192 2.9k
Chunling Zhang China 25 873 1.3× 297 0.5× 268 1.1× 271 1.2× 241 1.6× 75 2.4k
Ju‐Young Jung South Korea 30 936 1.3× 286 0.5× 313 1.3× 171 0.7× 142 0.9× 143 2.7k
Kaori Ishida Japan 31 753 1.1× 411 0.7× 311 1.3× 271 1.2× 125 0.8× 119 2.9k
Sergio Castorina Italy 28 877 1.3× 420 0.7× 433 1.8× 272 1.2× 111 0.7× 142 2.6k
Ling Hu China 25 633 0.9× 173 0.3× 308 1.3× 209 0.9× 159 1.1× 154 2.1k
Maria Papaioannou Greece 22 462 0.7× 279 0.5× 156 0.6× 284 1.2× 155 1.0× 85 1.3k
Jian Shen China 27 832 1.2× 293 0.5× 189 0.8× 168 0.7× 108 0.7× 110 2.2k
Kai Su China 23 678 1.0× 176 0.3× 254 1.0× 367 1.6× 125 0.8× 71 1.9k
Bin Wu China 27 1.1k 1.6× 335 0.6× 163 0.7× 404 1.7× 92 0.6× 121 2.3k

Countries citing papers authored by Ziqiang Luo

Since Specialization
Citations

This map shows the geographic impact of Ziqiang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqiang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqiang Luo more than expected).

Fields of papers citing papers by Ziqiang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqiang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqiang Luo. The network helps show where Ziqiang Luo may publish in the future.

Co-authorship network of co-authors of Ziqiang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqiang Luo. A scholar is included among the top collaborators of Ziqiang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqiang Luo. Ziqiang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
He, Bin, Wenjie Huang, Bing Wu, et al.. (2024). PGC1-Alpha/Sirt3 Signaling Pathway Mediates the Anti-Pulmonary Fibrosis Effect of Hirudin by Inhibiting Fibroblast Senescence. Biomedicines. 12(7). 1436–1436. 3 indexed citations
5.
Zhang, Xiaohua, Xiaoting Huang, Tingting Zhou, et al.. (2024). NBR1-p62-Nrf2 mediates the anti-pulmonary fibrosis effects of protodioscin. Chinese Medicine. 19(1). 60–60. 5 indexed citations
6.
Zeng, Yan‐Jun, Rui Hu, Wei Ma, et al.. (2024). New tricks for old drugs- praziquantel ameliorates bleomycin-induced pulmonary fibrosis in mice. BMC Pharmacology and Toxicology. 25(1). 18–18.
7.
Cheng, Haipeng, Dandan Feng, Xiaohong Li, et al.. (2023). NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119535–119535. 10 indexed citations
8.
Chen, Chen, et al.. (2023). An online flipped classroom approach improves the physiology score and subsequent course scores of the top-performing students. AJP Advances in Physiology Education. 47(3). 538–547. 5 indexed citations
9.
Zhou, Yan, Yanfen Chang, Xinyue Liang, et al.. (2022). The Effects of Ventilation, Humidity, and Temperature on Bacterial Growth and Bacterial Genera Distribution. International Journal of Environmental Research and Public Health. 19(22). 15345–15345. 94 indexed citations
10.
Li, Jiaxi, Pu Huang, Jing Xiong, et al.. (2022). Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids. Endocrine Connections. 11(5). 20 indexed citations
11.
Cheng, Yan, Xiaoxue He, S. V. G. N. Priyadarshani, et al.. (2021). Assembly and comparative analysis of the complete mitochondrial genome of Suaeda glauca. BMC Genomics. 22(1). 167–167. 130 indexed citations
12.
Zhao, Feiyan, Wei Liu, Shaojie Yue, et al.. (2019). Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis. Stem Cells International. 2019. 1–13. 17 indexed citations
13.
Fang, Lijuan, Qingmei Cheng, Feiyan Zhao, et al.. (2019). Cigarette smoke exposure combined with lipopolysaccharides induced pulmonary fibrosis in mice. Respiratory Physiology & Neurobiology. 266. 9–17. 8 indexed citations
14.
Huang, Xiaoting, Chen Li, Jia Guo, et al.. (2017). An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes. Scientific Reports. 7(1). 44120–44120. 74 indexed citations
15.
Liao, Zhengchang, Xiaocheng Zhou, Ziqiang Luo, et al.. (2016). N-Methyl-D-aspartate Receptor Excessive Activation Inhibited Fetal Rat Lung DevelopmentIn VivoandIn Vitro. BioMed Research International. 2016. 1–11. 11 indexed citations
16.
Liu, Wei, Dandan Feng, Jianzhong Han, et al.. (2014). [Protective effect of NMDA receptor antagonist memantine on acute lung injury in mice].. PubMed. 39(1). 12–6. 8 indexed citations
17.
Guo, Yi, Xiong Deng, Jie Zhang, et al.. (2012). Analysis of the MRPL3, DNAJC13 and OFCC1 variants in Chinese Han patients with TS-CTD. Neuroscience Letters. 517(1). 18–20. 3 indexed citations
18.
Guo, Yi, Hua Lin, Kai Gao, et al.. (2011). Genetic analysis of IREB2, FAM13A and XRCC5 variants in Chinese Han patients with chronic obstructive pulmonary disease. Biochemical and Biophysical Research Communications. 415(2). 284–287. 22 indexed citations
19.
Han, Jianzhong, Chen Li, Huijun Liu, et al.. (2008). Inhibition of lipopolysaccharide‐mediated rat alveolar macrophage activation in vitro by antiflammin‐1. Cell Biology International. 32(9). 1108–1115. 7 indexed citations
20.
Li, Chen, Jianzhong Han, Lian Li, et al.. (2007). Interaction of antiflammin-1 with uteroglobin-binding protein induces phosphorylation of ERK1/2 in NIH 3T3 cells. Peptides. 28(11). 2137–2145. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026